Form 8-K - Current report:
SEC Accession No. 0001651308-19-000043
Filing Date
2019-05-09
Accepted
2019-05-09 16:16:23
Documents
3
Period of Report
2019-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxq1earnings.htm 8-K 32528
2 EXHIBIT 99.1 exhibit991q119earningsrele.htm EX-99.1 127060
3 bgnelogo.jpg GRAPHIC 157238
  Complete submission text file 0001651308-19-000043.txt   377345
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 19810747
SIC: 2834 Pharmaceutical Preparations